Maa: Euroopan unioni
Kieli: englanti
Lähde: EMA (European Medicines Agency)
pioglitazone hydrochloride
Teva Pharma B.V.
A10BG03
pioglitazone
Drugs used in diabetes
Diabetes Mellitus, Type 2
Pioglitazone is indicated in the treatment of type-2 diabetes mellitus as monotherapy: , in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance. , Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance. After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c). In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.,
Revision: 13
Withdrawn
2012-03-26
29 B. PACKAGE LEAFLET Medicinal Product no longer authorised 30 PACKAGE LEAFLET: INFORMATION FOR THE USER PIOGLITAZONE TEVA PHARMA 15 MG TABLETS PIOGLITAZONE TEVA PHARMA 30 MG TABLETS PIOGLITAZONE TEVA PHARMA 45 MG TABLETS Pioglitazone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Pioglitazone Teva Pharma is and what it is used for 2. What you need to know before you take Pioglitazone Teva Pharma 3. How to take Pioglitazone Teva Pharma 4. Possible side effects 5. How to store Pioglitazone Teva Pharma 6. Contents of the pack and other information 1. WHAT PIOGLITAZONE TEVA PHARMA IS AND WHAT IT IS USED FOR Pioglitazone Teva Pharma contains pioglitazone. It is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus in adults, when metformin is not suitable or has failed to work adequately. This is the diabetes that usually develops in adulthood. Pioglitazone Teva Pharma helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces. Your doctor will check whether Pioglitazone Teva Pharma is working 3 to 6 months after you start taking it. Pioglitazone Teva Pharma may also be used in patients who are unable to take metformin, and where treatment with diet and exercise has failed to control blood sugar or may be added to insulin therapy when it fails to provide sufficient control of blood sugar. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PIOGLITAZONE TEVA PHARMA DO NOT TAKE PIOGLITAZONE TEVA Lue koko asiakirja
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Medicinal Product no longer authorised 2 1. NAME OF THE MEDICINAL PRODUCT Pioglitazone Teva Pharma 15 mg tablets Pioglitazone Teva Pharma 30 mg tablets Pioglitazone Teva Pharma 45 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Pioglitazone Teva Pharma 15 mg tablets Each tablet contains 15 mg of pioglitazone (as hydrochloride). Pioglitazone Teva Pharma 30 mg tablets Each tablet contains 30 mg of pioglitazone (as hydrochloride). Pioglitazone Teva Pharma 45 mg tablets Each tablet contains 45 mg of pioglitazone (as hydrochloride). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Pioglitazone Teva Pharma 15 mg tablets The tablets are white to off-white, round, convex and debossed with the number ‘15’ on one side and ‘TEVA’ on the other side. Pioglitazone Teva Pharma 30 mg tablets The tablets are white to off-white, round, convex and debossed with the number ‘30’ on one side and ‘TEVA’ on the other side. Pioglitazone Teva Pharma 45 mg tablets The tablets are white to off-white, round, convex and debossed with the number ‘45’ on one side and ‘TEVA’ on the other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as MONOTHERAPY - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance (see section 4.4). After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA 1c ). In patients who fail to show an adequate response, pioglitazone should be discontinued. In Lue koko asiakirja